Trademark applications and grants for Ucb Biopharma Sprl. Ucb Biopharma Sprl has 90 trademark applications. The latest application filed is for "KYROZIGG"
Patent Application | Date |
---|---|
9H-PYRROLO-DIPYRIDINE DERIVATIVES 20220213103 - 17/700075 Mercier; Joel ;   et al. | 2022-07-07 |
ANTIBODIES SPECIFIC TO FCRN 20220162311 - 17/643506 ATHERFOLD; Paul Alan ;   et al. | 2022-05-26 |
BIOLOGICAL PRODUCTS 20210371547 - 17/151911 TICKLE; Simon Peter ;   et al. | 2021-12-02 |
Proteins and Uses 20210301012 - 16/342800 Wright; Michael John ;   et al. | 2021-09-30 |
METHOD FOR INCREASING THE PERCENTAGE OF MONOMERIC ANTIBODY FAB-DSFV MULTIMERIC SPECIES 20210079120 - 17/078130 HEYWOOD; SAM PHILIP ;   et al. | 2021-03-18 |
Single linker FabFv antibodies and methods of producing same 11,401,349 - 16/573,893 Dave , et al. August 2, 2 | 2022-08-02 |
Process for obtaining antibodies 11,384,136 - 16/674,003 Bilgischer , et al. July 12, 2 | 2022-07-12 |
Anti-FcRn antibodies 11,384,148 - 16/271,086 Finney , et al. July 12, 2 | 2022-07-12 |
Multimeric Fc proteins 11,352,414 - 15/123,038 Fallah-Arani , et al. June 7, 2 | 2022-06-07 |
Cap for an injector 11,331,438 - 16/608,465 Knight , et al. May 17, 2 | 2022-05-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.